PharmAla Biotech Holdings, Inc. Financial Overview
PharmAla Biotech Holdings, Inc.'s market cap is currently C$12.15M. The company's EPS TTM is C$-0.005; its P/E ratio is ―; PharmAla Biotech Holdings, Inc. is scheduled to report earnings on July 25, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Currency in CAD
PharmAla Biotech Holdings, Inc. Earnings and Revenue History
